The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Benmelstobart (TQB2450) combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent, or metastatic endometrial cancer: A multicohort, open label, multicenter, phase II clinical trial (TQB2450-II-08).
 
Xiaohua Wu
No Relationships to Disclose
 
Xiaojun Chen
No Relationships to Disclose
 
Ke Wang
No Relationships to Disclose
 
Dong Wang
No Relationships to Disclose
 
Ruifang An
No Relationships to Disclose
 
Jianqing Hou
No Relationships to Disclose
 
Ying Yang
No Relationships to Disclose
 
Danbo Wang
No Relationships to Disclose
 
Pengpeng Qu
No Relationships to Disclose
 
Bingzhong Zhang
No Relationships to Disclose
 
Wei Duan
No Relationships to Disclose
 
Xiumin Li
No Relationships to Disclose
 
Ai-min Zang
No Relationships to Disclose
 
Guohua Yu
No Relationships to Disclose
 
Hanmei Lou
No Relationships to Disclose
 
Desheng Yao
No Relationships to Disclose
 
Shuzhen Wang
No Relationships to Disclose
 
Dong Yan
No Relationships to Disclose
 
Liang Li
No Relationships to Disclose
 
Xiaowei Liu
No Relationships to Disclose